Washington Biotechnology, Inc.
|
_____________________________________
Innovation . Experience . Reliability . Speed
__________________________________________
WBI In Vivo Disease Models
Optimizing Your Disease Model Study
To fully benefit from your disease model study, preliminary in vivo analysis can make a significant difference in both time and money invested.
WBI offers in vivo services to optimize your dose selection. Our team of scientists provides expert recommendations for:
- Formulations
- MTD analysis - Selection of optimal dose avoiding toxicity
- PK analysis - Selection of optimal dose & timing strategy
- Dose/Route/Timing - To fit a specific Disease Model
We understand your need for speed - and expedite to match. WBI services are provided with rapid start-up & completion.
To request a schedule, protocol and quote please contact us.
Washington Biotechnology, Inc. (WBI)
In Vivo CRO Partner of Choice
Since 1988
|